Scaglione Giovanni, Colaneri Marta, Offer Martina, Galli Lucia, Borgonovo Fabio, Genovese Camilla, Fattore Rebecca, Schiavini Monica, Taino Alba, Calloni Maria, Casella Francesco, Gidaro Antonio, Fassio Federico, Breschi Valentina, Leoni Jessica, Cogliati Chiara, Gori Andrea, Foschi Antonella
Division of Infectious Diseases, Luigi Sacco Hospital, University of Milan, 20157 Milan, Italy.
Division of Infectious Diseases, Fondazione IRCCS Policlinico San Matteo, 27100 Pavia, Italy.
Microorganisms. 2024 Aug 6;12(8):1597. doi: 10.3390/microorganisms12081597.
Vascular access devices (VADs), namely peripheral VADs (PVADs) and central venous VADs (CVADs), are crucial in both intensive care unit (ICU) and non-ICU settings. However, VAD placement carries risks, notably catheter-related bloodstream infections (CRBSIs). spp. is a common pathogen in CRBSIs, yet its clinical and microbiological characteristics, especially in non-ICU settings, are underexplored.
We conducted a monocentric, retrospective observational study at Luigi Sacco Hospital from 1 May 2021 to 1 September 2023. We reviewed medical records of non-ICU adult patients with CVADs and PVADs. Data on demographics, clinical and laboratory results, VAD placement, and CRBSI occurrences were collected. Statistical analysis compared spp. CRBSI and bacterial CRBSI groups.
Out of 1802 VAD placements in 1518 patients, 54 cases of CRBSI were identified, and spp. was isolated in 30.9% of episodes. The prevalence of CRBSI was 3.05%, with spp. accounting for 0.94%. Incidence rates were 2.35 per 1000 catheter days for CRBSI, with and non-albicans at 0.47 and 0.26 per 1000 catheter days, respectively-patients with spp. CRBSI had more frequent SARS-CoV-2 infection, COVID-19 pneumonia, and hypoalbuminemia.
During the COVID-19 pandemic, spp. was a notable cause of CRBSIs in our center, underscoring the importance of considering spp. in suspected CRBSI cases, including those in non-ICU settings and in those with PVADs.
血管通路装置(VADs),即外周血管通路装置(PVADs)和中心静脉血管通路装置(CVADs),在重症监护病房(ICU)和非ICU环境中都至关重要。然而,VAD置入存在风险,尤其是导管相关血流感染(CRBSIs)。[具体菌种]是CRBSIs中的常见病原体,但其临床和微生物学特征,特别是在非ICU环境中的特征,尚未得到充分研究。
我们于2021年5月1日至2023年9月1日在路易吉·萨科医院进行了一项单中心回顾性观察研究。我们回顾了非ICU成年CVADs和PVADs患者的病历。收集了人口统计学、临床和实验室结果、VAD置入以及CRBSI发生情况的数据。统计分析比较了[具体菌种]CRBSI组和细菌性CRBSI组。
在1518例患者的1802次VAD置入中,确定了54例CRBSI,[具体菌种]在30.9%的病例中被分离出来。CRBSI的患病率为3.05%,[具体菌种]占0.94%。CRBSI的发病率为每1000导管日2.35例,[具体菌种]和非白色念珠菌分别为每1000导管日0.47例和0.26例。患有[具体菌种]CRBSI的患者更频繁地发生严重急性呼吸综合征冠状病毒2(SARS-CoV-2)感染、冠状病毒病2019(COVID-19)肺炎和低白蛋白血症。
在冠状病毒病2019(COVID-19)大流行期间,[具体菌种]是我们中心CRBSIs的一个显著原因,强调了在疑似CRBSI病例中考虑[具体菌种]的重要性,包括非ICU环境中的病例和PVADs患者。